Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lymphoma Clinical Trials in Washington | 859 Studies

Clinical Trials LymphomaWashington

Lymphoma Clinical Trials in Washington

Find 859 clinical trials for lymphoma near Washington. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 859 trials

CompletedStudy of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell LymphomaThe goal of this clinical study is to assess whether axicabtagene ciloleucel therapy improves the clinical outcome compared with standard of care second-line therapy in…NCT03391466·Gilbert, Arizona and 71 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingNT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell LymphomaDiffuse large B-cell lymphoma is the most commonly occurring subtype of non-Hodgkin lymphoma, but treatment is often not curative, with as many as 50% of patients with adverse…NCT07052305·St Louis, Missouri

TerminatedPembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell LymphomaThis phase II trial studies how well pembrolizumab with rituximab or obinutuzumab work in treating patients with follicular lymphoma or diffuse large B cell lymphoma that has come…NCT03401853·Seattle, Washington

TerminatedPRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR StudyThe main objective of this clinical trial is to study the efficacy and safety of cobomarsen (also known as MRG-106) for the treatment of cutaneous T-cell lymphoma (CTCL), mycosis…NCT03837457·Phoenix, Arizona and 8 others

CompletedReal World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)This is a prospective, observational, non-interventional, international, multi-center, mixed methods study that will involve the integration of quantitative and qualitative data…NCT05455931·Baltimore, Maryland and 18 others

CompletedRituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies, such as rituximab and galiximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00117975·Washington D.C., District of Columbia and 67 others

Active not recruitingStudy to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 TabletsB-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections.NCT05618028·Los Angeles, California and 38 others

Active not recruitingChemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic LeukemiaThis phase II clinical trial tests a chemotherapy regimen (dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin with or without rituximab…NCT05453500·Seattle, Washington

CompletedA Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular LymphomaThis is a phase 2, single-arm, open label, multicenter study evaluating the efficacy and safety of the combination of VELCADE, bendamustine, and rituximab in subjects with…NCT00636792·Washington D.C., District of Columbia and 1 other

CompletedA Study of INCB050465 in Relapsed or Refractory Follicular LymphomaThe purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma.NCT03126019·Phoenix, Arizona and 82 others

Active not recruitingCholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D InsufficiencyThis partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency.NCT01787409·Scottsdale, Arizona and 4 others

RecruitingA Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care MogamulizumabThis study is being done to assess mogamulizumab-associated rash in patients diagnosed with mycosis fungoides or sezary syndrome and treated with standard of care mogamulizumab.NCT07003100·Duarte, California and 9 others

CompletedStudy of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell LymphomaThe purpose of this study is to establish the safety and optimal dose of orally administered PCI-32765 in patients with recurrent B cell lymphoma.NCT00849654·Palo Alto, California and 8 others

CompletedThe Second Multicenter Hemophilia Cohort StudyThe Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus…NCT00341705·Tucson, Arizona and 47 others

TerminatedA Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)This open-label, randomized, parallel group study will evaluate the efficacy and safety of obinutuzumab in combination with cyclophosphamide, doxorubicin, vincristine, and…NCT01287741·Birmingham, Alabama and 234 others

CompletedAssessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1The main purpose of this study is to see if Positron Emission Tomography (PET) imaging with a radioactive tracer called 18F-ISO-1 can accurately identify how quickly cancer cells…NCT00968656·St Louis, Missouri

RecruitingTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerThe purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to…NCT02693535·Birmingham, Alabama and 180 others

CompletedA Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)This trial will study brentuximab vedotin to find out whether it is an effective treatment for Hodgkin lymphoma (HL) and peripheral T-cell lymphoma (PTCL).NCT01716806·Birmingham, Alabama and 53 others

CompletedStudy of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaThis study is being conducted to identify how much and how often pralatrexate, given with vitamin B12 and folic acid, can be given safely to patients with cutaneous T-cell…NCT00554827·Duarte, California and 9 others

CompletedSafety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological MalignanciesCurrent protocols use G-CSF to mobilize hematopoietic progenitor cells from matched sibling and volunteer unrelated donors.NCT02639559·Atlanta, Georgia and 2 others

PreviousPage 8 of 43Next

Other Conditions in Washington

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia